BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 2409543)

  • 1. Evaluation of the efficacy of flecainide acetate in the treatment of ventricular premature contractions.
    Muhiddin KA; Turner P; Hellestrand K; Camm AJ
    Postgrad Med J; 1985 Jun; 61(716):489-96. PubMed ID: 2409543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sinusoidal ventricular tachycardia associated with flecainide acetate.
    Sellers TD; DiMarco JP
    Chest; 1984 May; 85(5):647-9. PubMed ID: 6201323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral flecainide for suppression of ventricular arrhythmias.
    Vanhaleweyk G; Balakumaran K; Lubsen J; Roelandt J; Hugenholtz PG
    Cardiology; 1984; 71(1):30-9. PubMed ID: 6722846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A double-blind, crossover comparison of flecainide acetate and disopyramide phosphate in the treatment of ventricular premature complexes.
    Kjekshus J; Bathen J; Orning OM; Storstein L
    Am J Cardiol; 1984 Feb; 53(5):72B-78B. PubMed ID: 6421140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of flecainide with quinidine for suppression of chronic stable ventricular ectopic depolarizations. A double-blind randomized study in ambulatory outpatients.
    Salerno DM; Hodges M; Granrud G; Sharkey P
    Ann Intern Med; 1983 Apr; 98(4):455-60. PubMed ID: 6340575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antiarrhythmic efficacy of mexiletine, propafenone and flecainide in ventricular premature beats. A comparative study in patients after myocardial infarction (author's transl)].
    Klempt HW; Nayebagha A; Fabry E
    Z Kardiol; 1982 May; 71(5):340-9. PubMed ID: 6180562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of flecainide acetate in the treatment of premature ventricular contractions.
    Abitbol H; Califano JE; Abate C; Beilis P; Castellanos H
    Am Heart J; 1983 Feb; 105(2):227-30. PubMed ID: 6823803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flecainide: electrophysiologic and antiarrhythmic properties in refractory ventricular tachycardia.
    Platia EV; Estes M; Heine DL; Griffith LS; Garan H; Ruskin JN; Reid PR
    Am J Cardiol; 1985 Apr; 55(8):956-62. PubMed ID: 3984883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparative study of a slow-release quinidine preparation and flecainide administered in 2 daily doses for the treatment of extrasystole].
    Clémenty J; Castagne D; Dallocchio M; Bricaud H
    Ann Cardiol Angeiol (Paris); 1984 Oct; 33(6):401-5. PubMed ID: 6208841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and tolerance of intravenous flecainide in patients with chronic high frequency ventricular arrhythmias.
    Stroobandt R; Andries E; van Mieghem W; Kesteloot H
    Eur Heart J; 1984 Nov; 5(11):876-82. PubMed ID: 6397356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flecainide versus quinidine: results of a multicenter trial.
    Hodges M; Salerno DM; Granrud G
    Am J Cardiol; 1984 Feb; 53(5):66B-71B. PubMed ID: 6364770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term efficacy of oral pirmenol in suppressing ventricular premature depolarizations.
    de Buitleir M; Crevey BJ; Johnson T; Kou WH; Nelson SD; Schmaltz S; Morady F
    Am Heart J; 1988 Aug; 116(2 Pt 1):379-84. PubMed ID: 2456681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A double-blind crossover comparison of flecainide and slow-release mexiletine in the treatment of stable premature ventricular complexes.
    Capucci A; Di Pasquale G; Boriani G; Carini G; Balducelli M; Frabetti L; Carozzi A; Finzi A; Pinelli G; Magnani B
    Int J Clin Pharmacol Res; 1991; 11(1):23-33. PubMed ID: 1714885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiarrhythmic efficacy of pirmenol in the treatment of premature ventricular complexes.
    Toivonen LK; Nieminen MS; Manninen V; Frick MH
    Eur Heart J; 1985 Sep; 6(9):737-44. PubMed ID: 2416566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Flecainide versus quinidine for treatment of chronic ventricular arrhythmias. A multicenter clinical trial.
    Circulation; 1983 May; 67(5):1117-23. PubMed ID: 6339110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cifenline in the short-term treatment of patients with ventricular premature complexes: a double-blind placebo-controlled study.
    Kostis JB; Davis D; Kluger J; Aogaichi K; Smith M
    J Cardiovasc Pharmacol; 1989 Jul; 14(1):88-95. PubMed ID: 2475722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Long-term therapy with flecainide].
    Bramann HU; Bender F; Jachmann H; Grosse-Heitmeyer W
    Z Kardiol; 1984 Nov; 73(11):724-31. PubMed ID: 6084367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flecainide in the treatment of nonsustained ventricular tachycardia.
    Lal R; Chapman PD; Naccarelli GV; Schechtman KB; Rinkenberger RL; Troup PJ; Kim SS; Dougherty AH; Ruffy R
    Ann Intern Med; 1986 Oct; 105(4):493-8. PubMed ID: 3752754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute effects of antiarrhythmic drugs on stable ventricular premature beats. Controlled comparison of lorcainide and lidocaine.
    Schmidt G; Klein G; Wirtzfeld A
    Eur J Clin Pharmacol; 1985; 27(6):633-6. PubMed ID: 2580712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of flecainide on chronic ventricular arrhythmias (author's transl)].
    Bluschke V; Breithardt G; Abendroth RR; Seipel L
    Z Kardiol; 1982 Apr; 71(4):284-8. PubMed ID: 6178228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.